{"id":"W1999442391","doi":"10.1016/s1470-2045(08)70177-3","title":"Part II: Milestones in personalised medicine—trastuzumab","year":2008,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Trastuzumab; Oncology; Medicine; Imatinib; Breast cancer; Internal medicine; Oncogene; Cancer; Ovarian cancer; Cancer research; Bioinformatics; Myeloid leukemia; Biology; Cell cycle","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007151421,0.001222988,0.001032892,0.001267062,0.0007365068,0.004923431,0.001314179,0.008739082,0.007877147],"category_scores_gemma":[0.01149837,0.0005339826,0.0007269702,0.001286483,0.003935893,0.006552847,0.00256398,0.008978892,0.003309235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005217556,"about_ca_system_score_gemma":0.004135242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001848623,"about_ca_topic_score_gemma":0.002532695,"domain_scores_codex":[0.9967849,0.001224671,0.0002390373,0.0003129338,0.0009333546,0.0005049815],"domain_scores_gemma":[0.9933216,0.003710548,0.0005965672,0.0004781898,0.000932708,0.0009603259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002227785,0.0001198879,0.0003011946,0.001267923,0.0000457741,0.0001738523,0.0002418371,0.0006793644,0.001403839,0.09344388,0.6751105,0.2269891],"study_design_scores_gemma":[0.00007652391,0.0001510077,0.001426971,0.001359902,0.00002517688,0.0004046262,0.0001218737,0.0003463976,0.0008741585,0.03493176,0.96025,0.00003158599],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.00177736,0.5631853,0.003193898,0.3442625,0.05273302,0.0001255029,0.0001797524,0.0001105121,0.03443211],"genre_scores_gemma":[0.04742504,0.53036,0.004825184,0.2358069,0.1080372,0.000377492,0.0003995648,0.0001957996,0.0725729],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.008739082,"threshold_uncertainty_score":0.03785616,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.269792299096941,"score_gpt":0.452685699643005,"score_spread":0.182893400546064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}